- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03099915
Asthma Attack in the Emergency Department : Reasons Of This Attendance (AERO)
Objective: Identify modifiable factors that may affect asthma control and the use of emergency room to define customized interventions for the management of asthma prior to emergency room.
Emergency department attendance is always a sign of poor balance or control of asthma. In spite of a decrease in the number of deaths that has been halved in 20 years and hospitalization due to asthmatic disease, the use of emergency center for this disease has not decreased. We now know that the passage through emergencies and hospitalization for aggravation of asthma is in itself a factor of mortality. Acting on the determinants of poor balance or control of asthma is essential to further reduce the mortality and morbidity of asthma.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is two parts in this study:
Part 1 - Qualitative study by individual interviews until data saturation (although about ten patients should be enough to capture the concepts of interest) on the factors that induce an imbalance of asthma (based on the GINA (Global Initiative for Asthma) report whose criteria are validated).
An interview guide will be written to systematically address all aspects related to asthma control.
In agreement with the patient the interview will be recorded, and the verbatim will be transcribed and coded using a software (Nvivo version 10).
Preparation of a questionnaire
A questionnaire will be developed from:
- analysis of patient verbatim
- other data: GINA criteria, psychological criteria (psychological distress is assessed by the 12-item general health questionnaire (GHQ-12) which is valid psychometric tools in French) and social criteria.
Part 2-Observational cohort qualitative study. The questionnaire thus prepared will be placed in the patient file upon admission. As soon as possible it will be filled by the patient after improvement of his condition and collected by the doctor or nurse who took care of the patient.
To obtain sufficient power to demonstrate significant associations, and assuming that 15 variables are taken into account in a multivariate model and based on the recommendations of 10 subjects per variable, 150 patients are required.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Clichy, France, 92110
- Service d'accueil des urgences Hôpital Beaujon
-
Paris, France, 75018
- Service d'acceuil des urgences hôpital Bichat- Claude Bernard
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age> 18 years
- Ambulatory patient, visiting one of these centers
- Diagnosis of asthma already evolving for more than 6 months
- Prescription of treatment for more than 3 months
- Patient who can read and write French
- Agreement for an individual interview (Part 1) or fill up a self-questionnaire (Part 2)
- Health insurance coverage
Exclusion Criteria:
- Patients with other etiology that may explain their dyspnea: heart failure, chronic obstructive pulmonary disease , pneumopathy
- Patients with a social background that is not compatible with the study: a patient who does not speak French, is homeless or does not have a telephone number
- Inpatients
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Poor observance of GINA criteria
Time Frame: Less than 24 hours: the outcome measure will be assessed the visiting day at emergency room, when the asthma attack will be solved, before discharge from hospital
|
Explanation of Asthma imbalance by poor observance and knowledge of GINA global strategy for asthma management and prevention criteria.
|
Less than 24 hours: the outcome measure will be assessed the visiting day at emergency room, when the asthma attack will be solved, before discharge from hospital
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
GHQ-12 Psychometric tool
Time Frame: Less than 24 hours: the outcome measure will be assessed the visiting day at emergency room, when the asthma attack will be solved, before discharge from hospital
|
Psychological distress caused by asthma will be measured by general health questionnaire
|
Less than 24 hours: the outcome measure will be assessed the visiting day at emergency room, when the asthma attack will be solved, before discharge from hospital
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Olivier CHASSANY, MD, PhD, EA 7334, University Paris-Diderot, Paris
- Principal Investigator: Prabakar VAITTINADA AYAR, MD, Hopital Bichat-Claude Bernard
- Study Chair: Enrique CASALINO, MD, Hopital Bichat-Claude Bernard
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AERO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergency Medicine
-
Samsung Medical CenterRecruitingEmergency Medicine | Medical Informatics | Pediatric Emergency MedicineKorea, Republic of
-
RWTH Aachen UniversityCompletedTelemedicine | Disaster Medicine | Emergency MedicineGermany
-
Washington University School of MedicineEpharmix, Inc.CompletedEmergency Medicine | Mobile Health | General MedicineUnited States
-
Mario Negri Institute for Pharmacological ResearchCentre Hospitalier Universitaire Vaudois; Fondazione Bruno Kessler; Astir S.r.l. and other collaboratorsNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Massachusetts General HospitalTerminatedEmergency MedicineUnited States
-
Ataturk UniversityCompletedEmergency MedicineTurkey
-
University of AarhusAarhus University Hospital; Herning Hospital; Horsens Hospital; Randers Regional... and other collaboratorsCompleted
-
Sheba Medical CenterDr. Yahel Giat; Pr. Merav Lidar; Dr. Michael Dreyfuss; Dr. Avinoah Irony; Dr. Gabrieal...CompletedEMERGENCY MEDICINE
Clinical Trials on completion of self-reported questionnaires
-
University Paris 7 - Denis DiderotUniversity of Manchester; Hospital Vall d'Hebron; Hôpital Louis Mourier; EA 7334...CompletedIBS - Irritable Bowel Syndrome | General PopulationUnited Kingdom, France, Spain
-
Zealand University HospitalUnknownHematological CancerDenmark
-
Medical University of ViennaLund University; Helsinki University Central Hospital; Sykehuset Innlandet HF; University... and other collaboratorsCompletedAmputation | Prosthesis UserAustria, Finland, Germany, Norway, Sweden
-
University Hospital, MontpellierHospices Civils de Lyon; University Hospital, Strasbourg, France; Central Hospital... and other collaboratorsUnknown
-
University of CologneUnknown
-
University of CambridgeNot yet recruitingCancer | Weight Loss | Cachexia | Appetite Loss | Cachexia-Anorexia Syndrome
-
European Institute of OncologyRecruiting
-
European Institute of OncologyActive, not recruitingBreast Cancer | Endocrine Breast DiseasesItaly
-
University Hospital, MontpellierRecruiting
-
University of California, San FranciscoAmerican Society of Clinical Oncology; Conquer Cancer FoundationRecruitingGynecologic Cancer | Malignant Female Reproductive System Neoplasm | Gynecologic NeoplasmUnited States